טוען...
Resolution of post-adalimumab vitiligo with secukinumab in a patient with psoriasis vulgaris
Plaque psoriasis is a chronic debilitating condition, and biologic agents that inhibit tumor necrosis factor-α (TNF-α) are widely employed in management of the condition. Notwithstanding, several paradoxical adverse reactions have been reported with TNF-α inhibitors, including vasculitis, vitiligo,...
שמור ב:
| הוצא לאור ב: | Oxf Med Case Reports |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6996046/ https://ncbi.nlm.nih.gov/pubmed/32038878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omz134 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|